Statistical considerations for cardiovascular clinical trials straddling the continuum of pandemic phases

White, R., Lam, P., Lu, N., Su, X., Bergemann, T., Johnson, T., Stephens, D., Farb, A., Jaff, M., Lansky, A., Kirtane, A., Rymer, J., & Krucoff, M. (2024). Statistical considerations for cardiovascular clinical trials straddling the continuum of pandemic phases. Cardiovascular Revascularization Medicine, 69, 90–97. https://doi.org/10.1016/j.carrev.2024.06.008
Authors:
Roseann White
Peter Lam
Michael Jaff
Nelson Lu
Andrew Farb
Xiaolu Su
Tracy Bergemann
Terri Johnson
Dan Stephens
Alexandra Lansky
Ajay Kirtane
Jennifer Rymer
Mitchell Krucoff
Affiliated Authors:
Ajay Kirtane
Columbia Affiliation:
Author Keywords:
covid-19
global pandemic phases
missing data
bias
variability
statistical power
mitigations for increased heterogeneity
elink
Publication Type:
Article
Unique ID:
10.1016/j.carrev.2024.06.008
PMID:
38897847
DOI:
10.1016/j.carrev.2024.06.008
Journal:
Cardiovascular Revascularization Medicine
Publication Date:
Data Source:
Web of Science
Source Link:
View Web of Science Record

Record Created: